PTPN18 Serves as a Potential Oncogene for Glioblastoma by Enhancing Immune Suppression

Glioblastoma is characterized as one of the deadliest cancers in humans. The survival time is not improved by standard treatment. Although immunotherapy has revolutionized cancer treatment, the current therapy targets for glioblastoma patients are not satisfied. We systematically analyzed the expres...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tao, Yu, Yang, Ba, Xinlei, Zhang, Xiaonan, Zhang, Na, Wang, Guowen, Bai, Bin, Li, Tong, Zhao, Jiahui, Zhao, Yanjiao, Wang, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950791/
https://www.ncbi.nlm.nih.gov/pubmed/36846716
http://dx.doi.org/10.1155/2023/2994316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950791/
https://www.ncbi.nlm.nih.gov/pubmed/36846716
http://dx.doi.org/10.1155/2023/2994316

Ejemplares similares